Company Active PRIVATE-LIMITED-GUARANT-NSC

Company profile

British United Provident Association Limited(The)

UK company 00432511, incorporated on 3 April 1947.

Bupa Group - corporate news and financials | Bupa Group

Bupa is an international healthcare company. Our purpose is helping people live longer, healthier, happier lives and making a better world.

Company number
00432511
Incorporated
3 Apr 1947
Companies House status
Active

Company identity

Founded / incorporated
3 April 1947

Company number 00432511

Verify at Companies House
Legal name
BRITISH UNITED PROVIDENT ASSOCIATION LIMITED(THE)
Company type
PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Region
London
Registered address
1 ANGEL COURT
LONDON
UNITED KINGDOM
EC2R 7HJ
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

British United Provident Association Limited(The)
No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

7 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

11 Jul
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

06 Aug
2026

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzUzNzIxMDgwNWFkaXF6a2N4

Published 06 Aug 2026 08:20

06 Jul
2026

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzUzMDc2MjA4N2FkaXF6a2N4

Published 06 Jul 2026 15:49

27 Jun
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

03 Apr
1947

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2010
Funded years
2010
Age at first award
62 years

Projects

2010 Collaborative R&D

Regenerative medicine value systems: navigating the uncertainties

1 Apr 2010 to 31 Mar 2012

Awarded
£37,224
Total cost £74,448

Delivery of tools to navigate the regen med uncertainties. VALUE has delivered tools for developers, manufactures and funders to understand regulatory requirements, supply chain logistics and reimbursement decision processes. It has also developed innovative models for investment and manufacturing. Progress of the regenerative medicine industry is current...

Product types

Collaborative R&D